Ribavirin Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00982553The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
NCT00000699A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients
NCT00000772A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
NCT00000733Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
NCT00001015A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems
NCT00000833A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.